COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01889407
Brief Title: Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

First Submitted : June 26, 2013
First Submitted that Met QC Criteria : June 26, 2013
First Posted : June 28, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : April 18, 2015
Last Update Posted : April 21, 2015 (Estimate)